Presidio Property Trust Inc Preferred Series D

NASDAQ SQFTP

Download Data

Presidio Property Trust Inc Preferred Series D Shareholders' Equity for the year ending December 31, 2023: USD 50.93 M

Presidio Property Trust Inc Preferred Series D Shareholders' Equity is USD 50.93 M for the year ending December 31, 2023, a -70.77% change year over year. Shareholders' Equity is the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Presidio Property Trust Inc Preferred Series D Shareholders' Equity for the year ending December 31, 2022 was USD 174.24 M, a 212.99% change year over year.
  • Presidio Property Trust Inc Preferred Series D Shareholders' Equity for the year ending December 31, 2021 was USD 55.67 M, a 59.59% change year over year.
  • Presidio Property Trust Inc Preferred Series D Shareholders' Equity for the year ending December 31, 2020 was USD 34.88 M, a -10.97% change year over year.
  • Presidio Property Trust Inc Preferred Series D Shareholders' Equity for the year ending December 31, 2019 was USD 39.18 M.
NASDAQ: SQFTP

Presidio Property Trust Inc Preferred Series D

CEO -
IPO Date June 11, 2021
Location United States
Headquarters 4995 Murphy Canyon Road, San Diego, CA, United States, 92123
Employees 15
Sector Real Estate
Industry Reit - diversified
Description

Presidio is an internally managed, diversified REIT with holdings in model home properties which are triple-net leased to homebuilders, office, industrial, and retail properties. Presidio's model homes are leased to homebuilders located in Arizona, Illinois, Texas, Wisconsin, and Florida. Our office, industrial and retail properties are located primarily in Colorado, with properties also located in Maryland, North Dakota, Texas, and Southern California. While geographical clustering of real estate enables us to reduce our operating costs through economies of scale by servicing several properties with less staff, it makes us susceptible to changing market conditions in these discrete geographic areas, including those that have developed as a result of COVID-19. Presidio owns approximately 6.5% of the outstanding common stock of Conduit Pharmaceuticals Inc., a disease agnostic multi-asset clinical-stage disease-agnostic life science company providing an efficient model for compound development.

Similar companies

ATLCP

Atlanticus Holdings Corp Preferred

NA

NA

StockViz Staff

September 20, 2024

Any question? Send us an email